Evaluating the impact of age on prostate cancer overdiagnosis using long-term follow-up from a randomised trial
This study utilizing long-term data from the CAP randomized trial demonstrates that prostate cancer overdiagnosis increases substantially with age due to competing mortality risks, suggesting that opportunistic screening policies should be re-evaluated for older men.